Glial cells as key elements in the pathophysiology and treatment of bipolar disorder
- 24 October 2016
- journal article
- review article
- Published by Cambridge University Press (CUP) in Acta Neuropsychiatrica
- Vol. 29 (3) , 140-152
Abstract
Objective: The exact pathophysiology of bipolar disorder (BD) is not yet fully understood, and there are many questions in this area which should be answered. This review aims to discuss the roles of glial cells in the pathophysiology of BD and their contribution to the mechanism of action of mood-stabilising drugs.Methods: We critically reviewed the most recent advances regarding glial cell roles in the pathophysiology and treatment of BD and the neuroprotective and neurotrophic effects of these cells.Results: Postmortem studies revealed a decrease in the glial cell number or density in the specific layers of prefrontal and anterior cingulate cortex in the patients with BD, whereas there was no difference in other brain regions, such as entorhinal cortex, amygdala and hippocampus. Astrocytes and oligodendrocytes were the most important glial types that were responsible for the glial reduction, but microglia activation rather than loss may be implicated in BD. The decreased number or density of glial cells may contribute to the pathological changes observed in neurons in the patients with BD. Alteration of specific neurotrophic factors such as glial cell line-derived neurotrophic factor and S100B may be an important feature of BD. Glial cells mediate the therapeutic effects of mood-stabilising agents in the treatment of BD.Conclusion: Recent studies provide important evidence on the impairment of glial cells in the pathophysiology and treatment of BD. However, future controlled studies are necessary to elucidate different aspects of glial cells contribution to BD, and the mechanism of action of mood-stabilising drugs.Keywords
This publication has 133 references indexed in Scilit:
- Circulating levels of GDNF in bipolar disorderNeuroscience Letters, 2011
- The right journal for the right time - Cell & BioscienceCell & Bioscience, 2011
- Regulation of synaptic connectivity by gliaNature, 2010
- Astrocytes: biology and pathologyActa Neuropathologica, 2009
- Elevated serum levels of the glial marker protein S100B are not specific for schizophrenia or mood disordersMolecular Psychiatry, 2009
- Sulforaphane protects astrocytes against oxidative stress and delayed death caused by oxygen and glucose deprivationGlia, 2008
- Current issues in bipolar disorder: A critical reviewEuropean Neuropsychopharmacology, 2007
- Glial fibrillary acidic protein and glutamine synthetase in subregions of prefrontal cortex in schizophrenia and mood disorderNeuroscience Letters, 2006
- Increased cerebrospinal fluid levels of S100B protein in rat model of mania induced by ouabainLife Sciences, 2004
- Glial contributions to excitatory neurotransmission in cultured hippocampal cellsNature, 1994